1. Home
  2. PTRN vs CPRX Comparison

PTRN vs CPRX Comparison

Compare PTRN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTRN

Pattern Group Inc.

HOLD

Current Price

$28.46

Market Cap

3.5B

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.49

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTRN
CPRX
Founded
2013
2002
Country
United States
United States
Employees
2300
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.9B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
PTRN
CPRX
Price
$28.46
$31.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
1
Target Price
$19.56
$35.00
AVG Volume (30 Days)
2.8M
1.8M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.24
EPS
N/A
0.50
Revenue
N/A
$119,072,803.00
Revenue This Year
$27.89
$9.20
Revenue Next Year
$22.19
$10.51
P/E Ratio
N/A
$62.96
Revenue Growth
N/A
16.39
52 Week Low
$9.19
$19.05
52 Week High
$29.63
$32.56

Technical Indicators

Market Signals
Indicator
PTRN
CPRX
Relative Strength Index (RSI) 74.21 70.31
Support Level $10.48 $31.25
Resistance Level N/A $32.56
Average True Range (ATR) 1.40 0.04
MACD 0.23 -0.05
Stochastic Oscillator 86.28 90.91

Price Performance

Historical Comparison
PTRN
CPRX

About PTRN Pattern Group Inc.

Pattern Group Inc is an e-commerce accelerator that uses its technology platform, data science, and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics, and customer service. Brand partners that contract with the Company operate in various industries, including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors, and consumer electronics. The Company mainly derives its revenue in the United States by selling products to customers via online marketplaces. The company genrates majority of revenue from the US.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: